- Lobbying
- Lobbying by BASF Corporation
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Richard Gold | 3/91-2/93 Sp. Asst. for Env. Affrs., Sen. Lloyd Bentsen 3/93-11/94 Sp. Asst. to EPA Administrator Carol Browner |
Kerry Feehery | 9/09-1/11 Chief of Staff, Sen. George LeMieux 1/07-9/09 Director, State Office of Sen. LeMieux 1/05-1/07 Communiations Dir., Sen. Mel Martinez 7/04-1/05 Policy Analyst, S. Budget Committee 2/99-10/00 Press Secretary, Joint Economic Cmte. 1/97-2/99 Deputy Press Secretary, Sen. Connie Mack 1/95-1/97 Special Assistant, Sen. Connie Mack 8/94-1/95 Staff Assistant, Sen. Connie Mack |
Joel Roberson | 5/02-12/02 Committee Liason, H. Republican Conference 1/03-8/04 Floor Debate Coordinator, H. Republican Conference 5/05-8/05 Law Clerk, House Judiciary Committee |
Michael Werner | 91-93 Policy Advisor, Senate Democratic Committee |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Food & Drug Administration (FDA)
Type of Issue
Registration
Issue(s) they said they’d lobby about: FDA over the counter drug approval process..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate